NEWSROOM

CARDIALEN IN THE NEWS

EP Lab Digest

"Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment"

https://www.hmpgloballearningnetwork.com/site/eplab/news/cardialen-receives-fda-approval-conduct-clinical-trial-low-energy-atrial

 

Mass Device

"Cardialen gets FDA IDE nod for low-energy AFib treatment"

https://www.massdevice.com/cardialen-gets-fda-ide-nod-for-low-energy-afib-treatment/

 

Cardiac Rhythm News
"Cardialen gets FDA approval for study of its Multipulse Therapy for AF"

https://cardiacrhythmnews.com/cardialen-gets-fda-approval-for-study-of-its-multipulse-therapy-for-af/

 

MD+DI

"When They Go High We Go Low: Using Low Energy to Treat AFib"

https://www.mddionline.com/cardiovascular/when-they-go-high-we-go-low-using-low-energy-treat-afib

 

BioWorld

"Cardialen wins FDA IDE approval for low-energy pulse therapy"

https://www.bioworld.com/articles/513522-cardialen-wins-fda-ide-approval-for-low-energy-pulse-therapy?v=preview

 

Twin Cities Business
"Medtech Firm Cardialen to Kick Off Fifth Clinical Trial"

https://tcbmag.com/medical-device-maker-cardialen-to-kick-off-fifth-clinical-trial/

 

CARDIALEN PRESS RELEASES

11.17.21 PRESS RELEASE

Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment

09.16.21 PRESS RELEASE

Cardialen Awarded $3 Million Federal Grant

04.13.21 PRESS RELEASE

Cardialen Announces Positive Results from Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation

01.19.21 PRESS RELEASE

Cardialen Awarded $2.8 Million Federal Grant

01.19.21 BUSINESWIRE PRESS RELEASE

Cardialen Awarded $2.8 Million Federal Grant

10.10.18 PRESS RELEASE

Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy

10.10.18

Minneapolis startup Cardialen raises $17 million in venture capital

Star Tribune

 

 

Media contact:

Michael Walsh

(612) 718-8952

MichaelWalshCommunications.com